Skip to main content

Intracranial Pressure

0
Pipeline Programs
3
Companies
4
Clinical Trials
2 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

Compremium
CompremiumSwitzerland - Bern
1 program
CPMX3N/A2 trials
Active Trials
NCT07222826Recruiting15Est. Sep 2026
NCT07550361Withdrawn0Est. Apr 2026
CoMind
CoMindUK - London
1 program
CoMind Early Feasibility StudyN/A1 trial
Active Trials
NCT06368648Recruiting581Est. Nov 2026
Lundbeck
LundbeckDenmark - Copenhagen
1 program
Raumedic Neurovent-P-telN/A1 trial
Active Trials
NCT03594136Completed6Est. May 2023

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
CompremiumCPMX3
CompremiumCPMX3
CoMindCoMind Early Feasibility Study
LundbeckRaumedic Neurovent-P-tel

Clinical Trials (4)

Total enrollment: 602 patients across 4 trials

NCT07222826CompremiumCPMX3

Non-invasive Intracranial Pressure Estimation by Measurement of the Occlusion Pressure of the Isolated Periorbital Vein

Start: Sep 2025Est. completion: Sep 202615 patients
N/ARecruiting
NCT07550361CompremiumCPMX3

Validation of Non-Invasive Intracranial Pressure Estimation Using CPMX3 in the Periorbital Vein: A Feasibility Study in Pediatric Patients

Start: Apr 2025Est. completion: Apr 20260
N/AWithdrawn
NCT06368648CoMindCoMind Early Feasibility Study

CoMind Early Feasibility Study

Start: Nov 2024Est. completion: Nov 2026581 patients
N/ARecruiting
NCT03594136LundbeckRaumedic Neurovent-P-tel

New Reference Values for Intracranial Pressure

Start: Feb 2018Est. completion: May 20236 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

2 actively recruiting trials targeting 602 patients
3 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.